粒体自噬
神经退行性变
生物
线粒体
神经科学
疾病
品脱1
自噬
药物发现
计算生物学
生物信息学
作者
Ruixue Ai,Xu‐Xu Zhuang,Alexander S. Anisimov,Jiahong Lu,Evandro Fei Fang
出处
期刊:Autophagy
[Taylor & Francis]
日期:2022-02-07
卷期号:18 (4): 939-941
被引量:16
标识
DOI:10.1080/15548627.2022.2031382
摘要
Failed recognition and clearance of damaged mitochondria contributes to memory loss as well as Aβ and MAPT/Tau pathologies in Alzheimer disease (AD), for which there is an unmet therapeutic need. Restoring mitophagy to eliminate damaged mitochondria could abrogate metabolic dysfunction, neurodegeneration and may subsequently inhibit or slow down cognitive decline in AD models. We have developed a high-throughput machine-learning approach combined with a cross-species screening platform to discover novel mitophagy-inducing compounds from a natural product library and further experimentally validated the potential candidates. Two lead compounds, kaempferol and rhapontigenin, induce neuronal mitophagy and reduce Aβ and MAPT/Tau pathologies in a PINK1-dependent manner in both C. elegans and mouse models of AD. Our combinational approach provides a fast, cost-effective, and highly accurate method for identification of potent mitophagy inducers to maintain brain health.
科研通智能强力驱动
Strongly Powered by AbleSci AI